Tuesday 16 February 2016

FDA

With the announcement of FDA fast track status for the RSV compound, we know that BTA are talking to the FDA.

If so, then I wonder why they haven't announced the outcome of discussions with FDA about LANI, as they announced they would over a year ago?

For them to extract not a single $ for the LANI compound is ridiculous. Note that even Biocryst sold their much inferior flu compound to CSL.